Detalhe da pesquisa
1.
Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience.
Transpl Infect Dis
; 21(6): e13187, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31585500
2.
Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
Transplant Cell Ther
; 27(1): 85.e1-85.e6, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33053449
3.
Antifungal use in immunocompetent, critically ill patients with pneumonia does not improve clinical outcomes.
Heart Lung
; 45(6): 538-543, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27601213
4.
Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients.
Bone Marrow Transplant
; 55(8): 1687-1689, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31937928